Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
A pharma-vet offers a history lesson following our "Pfizer After Wyeth" interview
March 26, 2010
By: Tim Wright
Editor-in-Chief, Contract Pharma
By Robert A. Nash, Ph.D. I read “PGM After Wyeth” in the March 2010 issue of Contract Pharma with great interest. Unfortunately, the article never mentioned the role Lederle played in Wyeth’s success prior to the recent buyout by Pfizer. When I joined Lederle in 1960, Lederle and Pfizer were on the same level in terms of product lines and sales. In time, Pfizer became the world’s largest pharma company, while Lederle when downhill. I attribute it to the fact that Pfizer understood the pharmaceutical business, while American Cyanamid treated Achromycin etc. like another Formica or Melmac. The purpose of this post is to shine some light on the pharmaceutical industry of Rockland County. We retirees still call the complex in Pearl River, “Lederle Laboratories,” even though most of the signs are gone and Dr. Lederle’s portrait hangs on an obscure wall in the library. Dr. Ernst Lederle was born on State Island in the 1880’s, went to school in New York City and became a laboratory scientist. He worked for the NYC Board of Health and was interested in sanitary conditions for food production and the possibility of manufacturing antitoxins and vaccines. He purchased the 99-acre Jacob Toerfler dairy farm in Pearl River in 1907 and moved much of his research and manufacturing operations in bacteriology and biochemistry from NYC to that site. Dr. Lederle never lived in Rockland County and died of septicemia in 1921 (a condition that would have been easy to treat with the sulfa drugs and antibiotics manufactured by his company in the 1930’s and 1940’s). Under his successors, the Bell brothers (Frederic then William), the Lederle Antitoxin Laboratory produce antitoxins and vaccines for diphtheria, tetanus, typhoid, anthrax, smallpox, cholera and gas gangrene. In 1930, the facility in Pearl River was renamed Lederle Laboratories and research in the 1930’s developed pituitary, thyroid and digitalis extracts. Important sulfa drugs sourced from American Cyanamid were added to the product line in 1939. Dr. Wilbur G. Malcolm became generla manager in 1940 and brought in Dr. SubbaRow to head up the research program. Because of its fermentation capabilities, Lederle got into the penicillin production business during the second World War and also became the largest supplier of sterile blood plasma. During this period American Cyanamid took over full control of Lederle Laboratories. In 1945, Dr. Benjamin Duggar of the University of Wisconsin with a team of Lederle scientists discovered Aueromycin, to be followed by Achromycin, Declomycin and Minocycline. In the 1950’s, Diamox (diuretic) and Aristocort (anti-inflammatory steroid) were marketed, followed by Orimune (poliovirus vaccine) and Myambutol (anti-TB drug) in the 1960’s. In the 1970’s, Loxitane (anti-psychotic) and Asendin (anti-depressant) were added to the product line. The 1970’s and 1980’s saw the rebirth of the multivitamin business, culminating in the Centrum line. I was instrumental in getting the marketing department to think about the vitamin business during the 1970’s when there were no blockbusters coming out of research. The people in my development laboratories had developed the technology to product large capsule-shaped tablets, which could then be film-coated to reduce size and protect the stability of the vitamin-mineral formulas suggested by Dr. Leon Ellenbogen. Lederle was purchased from American Cyanamid in 1994 by American Home Products Corp., and the Pearl River operation was renamed Wyeth-Ayerst. American Home Products renamed itself Wyeth in 2002 and became a piece of Pfizer in 2009. Why do I go on at such length about Pearl River? After all, it’s the closest pharmaceutical operation to Contract Pharma’s offices!
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !